Mitochondrial Voltage-Dependent Anion Channel 1-Hexokinase-II Complex-Targeted Strategy for Melanoma Inhibition Using Designed Multiblock Peptide Amphiphiles
Language English Country United States Media print-electronic
Document type Journal Article
- Keywords
- VDAC1-derived amphiphilic peptides, cell-penetrating peptides (CPP), human melanoma cells, mitochondria-mediated apoptosis, protein−protein interaction inhibition, self-assembly, targeting VDAC1−HK-II complex,
- MeSH
- Apoptosis drug effects MeSH
- Hexokinase metabolism MeSH
- Humans MeSH
- Membrane Potential, Mitochondrial drug effects MeSH
- Mitochondrial Membranes drug effects MeSH
- Mitochondria drug effects MeSH
- Cell Line, Tumor MeSH
- Voltage-Dependent Anion Channel 1 metabolism MeSH
- Peptides pharmacology MeSH
- Surface-Active Agents pharmacology MeSH
- Antineoplastic Agents pharmacology MeSH
- Amino Acid Sequence MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Hexokinase MeSH
- HK2 protein, human MeSH Browser
- Voltage-Dependent Anion Channel 1 MeSH
- Peptides MeSH
- Surface-Active Agents MeSH
- Antineoplastic Agents MeSH
- VDAC1 protein, human MeSH Browser
Targeted therapies of melanoma are of urgent need considering the resistance of this aggressive type of cancer to chemotherapeutics. The voltage-dependent anion channel 1 (VDAC1)-hexokinase-II (HK-II) complex is an emerging target for novel anticancer therapies based on induced mitochondria-mediated apoptosis. The low cell membrane permeability of the anticancer 12-mer peptide N-Ter (RDVFTKGYGFGL) derived from the N-terminal fragment of the VDAC1 protein impedes the intracellular targeting. Here, novel multiblock VDAC1-derived cationic amphiphilic peptides (referred to as Pal-N-Ter-TAT, pFL-N-Ter-TAT, and Pal-pFL-N-Ter-TAT) are designed with a self-assembly propensity and cell-penetrating properties. The created multiblock amphiphilic peptides of partial α-helical conformations form nanoparticles of ellipsoid-like shapes and are characterized by enhanced cellular uptake. The amphiphilic peptides can target mitochondria and dissociate the VDAC1-HK-II complex at the outer mitochondrial membrane, which result in mitochondria-mediated apoptosis. The latter is associated with decrease of the mitochondrial membrane potential, cytochrome c release, and changes of the expression levels of the apoptotic proteins in A375 melanoma cells. Importantly, the mitochondrial VDAC1-derived amphiphilic peptides have a comparable IC50 value for melanoma cells to a small-molecule drug, sorafenib, which has been previously used in clinical trials for melanoma. These results demonstrate the potential of the designed peptide constructs for efficient melanoma inhibition.
College of Chemistry and Materials Science Shanghai Normal University Shanghai 200234 P R China
Helmholtz Zentrum Hereon Geesthacht D 21502 Germany
Université Paris Saclay CNRS Institute Galien Paris Saclay UMR8612 Châtenay Malabry F 92290 France
References provided by Crossref.org